• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4657932)   Today's Articles (3969)   Subscriber (51250)
For: Gasior M, Bond M, Malamut R. Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations. Postgrad Med 2015;128:85-96. [DOI: 10.1080/00325481.2016.1120642] [Citation(s) in RCA: 49] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Number Cited by Other Article(s)
1
DeVito EE, Ameral V, Sofuoglu M. Sex differences in comorbid pain and opioid use disorder: A scoping review. Br J Clin Pharmacol 2024;90:3067-3083. [PMID: 39168150 PMCID: PMC11604518 DOI: 10.1111/bcp.16218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2023] [Revised: 07/17/2024] [Accepted: 08/01/2024] [Indexed: 08/23/2024]  Open
2
Webster L, Gudin J. Review of Opioid Abuse-Deterrent Formulations: Impact and Barriers to Access. J Pain Res 2024;17:1989-2000. [PMID: 38854928 PMCID: PMC11162618 DOI: 10.2147/jpr.s457982] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2024] [Accepted: 05/06/2024] [Indexed: 06/11/2024]  Open
3
Coffey KR, Nickelson WB, Dawkins AJ, Neumaier JF. Rapid appearance of negative emotion during oral fentanyl self-administration in male and female rats. Addict Biol 2023;28:e13344. [PMID: 38017643 PMCID: PMC10745948 DOI: 10.1111/adb.13344] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2023] [Revised: 09/14/2023] [Accepted: 09/21/2023] [Indexed: 11/30/2023]
4
Camazine MN, Rountree KM, Smith JB, Bath J, Vogel TR. Opioid utilization after lower extremity amputation for peripheral vascular disease and discharge prescribing recommendations. Vascular 2023;31:954-960. [PMID: 35506989 DOI: 10.1177/17085381221097163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
5
Mannaioni G, Lugoboni F. Precautions in the management of opioid agonist therapy: from target population characteristics to new formulations and post-marketing monitoring - a focus on the Italian system. Drugs Context 2023;12:2023-2-6. [PMID: 37664791 PMCID: PMC10470859 DOI: 10.7573/dic.2023-2-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2023] [Accepted: 06/29/2023] [Indexed: 09/05/2023]  Open
6
Cibulsky SM, Wille T, Funk R, Sokolowski D, Gagnon C, Lafontaine M, Brevett C, Jabbour R, Cox J, Russell DR, Jett DA, Thomas JD, Nelson LS. Public health and medical preparedness for mass casualties from the deliberate release of synthetic opioids. Front Public Health 2023;11:1158479. [PMID: 37250077 PMCID: PMC10213671 DOI: 10.3389/fpubh.2023.1158479] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2023] [Accepted: 04/17/2023] [Indexed: 05/31/2023]  Open
7
Coffey KR, Nickelson W, Dawkins AJ, Neumaier JF. Rapid appearance of negative emotion during oral fentanyl self-administration in male and female rats. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2023:2023.04.27.538613. [PMID: 37163074 PMCID: PMC10168304 DOI: 10.1101/2023.04.27.538613] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/11/2023]
8
Ali MM, McClellan C, Mutter R, Rees DI. Recreational marijuana laws and the misuse of prescription opioids: Evidence from National Survey on Drug Use and Health microdata. HEALTH ECONOMICS 2023;32:277-301. [PMID: 36335085 DOI: 10.1002/hec.4620] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/30/2021] [Revised: 08/30/2022] [Accepted: 09/28/2022] [Indexed: 06/16/2023]
9
Enhanced Recovery After Surgery Patients Are Prescribed Fewer Opioids at Discharge: A Propensity-score Matched Analysis. Ann Surg 2023;277:e287-e293. [PMID: 34225295 DOI: 10.1097/sla.0000000000005042] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
10
Feng X, Wu KW, Balajee V, Leissa J, Ashraf M, Xu X. Understanding syringeability and injectability of high molecular weight PEO solution through time-dependent force-distance profiles. Int J Pharm 2023;631:122486. [PMID: 36521635 DOI: 10.1016/j.ijpharm.2022.122486] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2022] [Revised: 12/02/2022] [Accepted: 12/07/2022] [Indexed: 12/15/2022]
11
Kibria G, Bandaranayake B, Zheng J, Lee S, Cruz C. Stability of Abuse-deterrent properties of PEO-based Abuse-deterrent formulation. Int J Pharm 2023;631:122430. [PMID: 36493968 DOI: 10.1016/j.ijpharm.2022.122430] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2022] [Revised: 11/18/2022] [Accepted: 11/19/2022] [Indexed: 12/12/2022]
12
Vasiukhina A, Gad SF, Wellington EN, Wilmes DM, Yeo Y, Solorio L. PLA-PCL microsphere formulation to deter abuse of prescription opioids by smoking. Int J Pharm 2022;626:122151. [PMID: 36037985 PMCID: PMC10729914 DOI: 10.1016/j.ijpharm.2022.122151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2022] [Revised: 08/15/2022] [Accepted: 08/23/2022] [Indexed: 11/17/2022]
13
Amico KN, Arnold ME, Dourron MS, Solomon MG, Schank JR. The effect of concurrent access to alcohol and oxycodone on self-administration and reinstatement in rats. Psychopharmacology (Berl) 2022;239:3277-3286. [PMID: 35972517 DOI: 10.1007/s00213-022-06210-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/21/2022] [Accepted: 08/01/2022] [Indexed: 11/26/2022]
14
O’Brien C, Vemireddy R, Mohammed U, Barker DJ. Stress reveals a specific behavioral phenotype for opioid abuse susceptibility. J Exp Anal Behav 2022;117:518-531. [PMID: 35119105 PMCID: PMC9090955 DOI: 10.1002/jeab.738] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2021] [Revised: 12/22/2021] [Accepted: 01/06/2022] [Indexed: 11/07/2022]
15
Lalovic B, Shireman L, Shen DD, Cherrier M. Model-Based Analysis of the Influence of Alcohol Use and Age on Pharmacokinetics-Pharmacodynamics of Oral Oxycodone in Middle-Age and Older Community Dwelling Adults. J Clin Pharmacol 2022;62:1177-1190. [PMID: 35394079 DOI: 10.1002/jcph.2058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2022] [Accepted: 04/04/2022] [Indexed: 11/11/2022]
16
Iyer V, Woodward TJ, Pacheco R, Hohmann AG. A limited access oral oxycodone paradigm produces physical dependence and mesocorticolimbic region-dependent increases in DeltaFosB expression without preference. Neuropharmacology 2021;205:108925. [PMID: 34921830 DOI: 10.1016/j.neuropharm.2021.108925] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2021] [Revised: 12/02/2021] [Accepted: 12/11/2021] [Indexed: 01/07/2023]
17
Webster L, Schmidt WK. Dilemma of Addiction and Respiratory Depression in the Treatment of Pain: A Prototypical Endomorphin as a New Approach. PAIN MEDICINE 2021;21:992-1004. [PMID: 31165885 DOI: 10.1093/pm/pnz122] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
18
Mort SC, Díaz SR, Beverly EA. Using contact-based education to destigmatize opioid use disorder among medical students. TEACHING AND LEARNING IN MEDICINE 2021;33:196-209. [PMID: 33196302 DOI: 10.1080/10401334.2020.1820869] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
19
Soni A, Paprikar A, Lin S. Effect of alkalizing agent on abuse deterrent potential of multiple-unit ingestion of bilayer abuse-deterrent extended-release tablets using propranolol as model drug for opioids overdose crisis. Int J Pharm 2021;600:120480. [PMID: 33722755 DOI: 10.1016/j.ijpharm.2021.120480] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2020] [Revised: 03/04/2021] [Accepted: 03/06/2021] [Indexed: 12/25/2022]
20
Acute Pain Management of Chronic Pain Patients in Ambulatory Surgery Centers. Curr Pain Headache Rep 2021;25:1. [PMID: 33443656 DOI: 10.1007/s11916-020-00922-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/21/2020] [Indexed: 12/16/2022]
21
Balsamo D, Bajardi P, Salomone A, Schifanella R. Patterns of Routes of Administration and Drug Tampering for Nonmedical Opioid Consumption: Data Mining and Content Analysis of Reddit Discussions. J Med Internet Res 2021;23:e21212. [PMID: 33393910 PMCID: PMC7813634 DOI: 10.2196/21212] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2020] [Revised: 10/15/2020] [Accepted: 10/28/2020] [Indexed: 01/14/2023]  Open
22
Phillips AG, McGovern DJ, Lee S, Ro K, Huynh DT, Elvig SK, Fegan KN, Root DH. Oral prescription opioid-seeking behavior in male and female mice. Addict Biol 2020;25:e12828. [PMID: 31489746 DOI: 10.1111/adb.12828] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2019] [Revised: 08/15/2019] [Accepted: 08/16/2019] [Indexed: 01/23/2023]
23
McConnell SA, Brandner AJ, Blank BA, Kearns DN, Koob GF, Vendruscolo LF, Tunstall BJ. Demand for fentanyl becomes inelastic following extended access to fentanyl vapor self-administration. Neuropharmacology 2020;182:108355. [PMID: 33091459 PMCID: PMC7747488 DOI: 10.1016/j.neuropharm.2020.108355] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2020] [Revised: 09/29/2020] [Accepted: 10/12/2020] [Indexed: 12/21/2022]
24
Butreddy A, Sarabu S, Dumpa N, Bandari S, Repka MA. Extended release pellets prepared by hot melt extrusion technique for abuse deterrent potential: Category-1 in-vitro evaluation. Int J Pharm 2020;587:119624. [PMID: 32653597 PMCID: PMC7484191 DOI: 10.1016/j.ijpharm.2020.119624] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2020] [Revised: 07/02/2020] [Accepted: 07/04/2020] [Indexed: 01/08/2023]
25
Brown JR, Oh GY, Wang Y, Slavova S, Delcher C, Dasgupta N, Freeman PR. Variation in Abuse-Deterrent Formulation Opioid Prescribing in California, Florida, and Kentucky in 2018. J Rural Health 2020;37:23-28. [PMID: 32686223 DOI: 10.1111/jrh.12496] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
26
Finding the Hidden Risk Profiles of the United States Opioid Epidemic: Using a Person-Centered Approach on a National Dataset of Noninstitutionalized Adults Reporting Opioid Misuse. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2020;17:ijerph17124321. [PMID: 32560342 PMCID: PMC7345624 DOI: 10.3390/ijerph17124321] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/12/2020] [Revised: 06/15/2020] [Accepted: 06/16/2020] [Indexed: 01/04/2023]
27
Proper Disposal of Prescription Opioids in Southwest Virginia: Assessment of Patient, Physician, and Medical Student Beliefs and Practices. JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE 2020;26:259-269. [PMID: 32235208 DOI: 10.1097/phh.0000000000001153] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
28
Jiang Y, Murnane KS, Blough BE, Banga AK. Transdermal Delivery of the Free Base of 3-Fluoroamphetamine: In Vitro Skin Permeation and Irritation Potential. AAPS PharmSciTech 2020;21:109. [PMID: 32215773 DOI: 10.1208/s12249-020-01649-5] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2019] [Accepted: 02/25/2020] [Indexed: 11/30/2022]  Open
29
Barakh Ali SF, Dharani S, Afrooz H, Mohamed EM, Cook P, Khan MA, Rahman Z. Development of Abuse-Deterrent Formulations Using Sucrose Acetate Isobutyrate. AAPS PharmSciTech 2020;21:99. [PMID: 32133549 DOI: 10.1208/s12249-020-01646-8] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2019] [Accepted: 02/21/2020] [Indexed: 01/17/2023]  Open
30
Carinci AJ. Abuse-deterrent opioid analgesics: a guide for clinicians. Pain Manag 2020;10:55-62. [DOI: 10.2217/pmt-2019-0052] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]  Open
31
Shigematsu-Locatelli M, Kawano T, Koyama T, Iwata H, Nishigaki A, Aoyama B, Tateiwa H, Kitaoka N, Yokoyama M. Therapeutic experience with tramadol for opioid dependence in a patient with chronic low back pain: a case report. JA Clin Rep 2019;5:68. [PMID: 32026047 PMCID: PMC6967209 DOI: 10.1186/s40981-019-0289-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2019] [Accepted: 10/01/2019] [Indexed: 11/10/2022]  Open
32
Modeling drug exposure in rodents using e-cigarettes and other electronic nicotine delivery systems. J Neurosci Methods 2019;330:108458. [PMID: 31614162 DOI: 10.1016/j.jneumeth.2019.108458] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2019] [Revised: 10/05/2019] [Accepted: 10/06/2019] [Indexed: 12/25/2022]
33
Rege SV, Ngo DA, Ait-Daoud N, Holstege CP. Epidemiology of severe buprenorphine exposures reported to the U.S. Poison Centers. Drug Alcohol Depend 2019;202:115-122. [PMID: 31344599 DOI: 10.1016/j.drugalcdep.2019.05.015] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/15/2019] [Revised: 05/10/2019] [Accepted: 05/14/2019] [Indexed: 11/24/2022]
34
Description and Impact of a Comprehensive Multispecialty Multidisciplinary Intervention to Decrease Opioid Prescribing in Surgery. Ann Surg 2019;270:452-462. [DOI: 10.1097/sla.0000000000003462] [Citation(s) in RCA: 35] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
35
Butler SF, Black RA, Fleming AB. Relative Abuse of Crush-Resistant Prescription Opioid Tablets via Alternative Oral Modes of Administration. PAIN MEDICINE 2019;19:1613-1627. [PMID: 29016905 PMCID: PMC6084581 DOI: 10.1093/pm/pnx151] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
36
Blackwood CA, Leary M, Salisbury A, McCoy MT, Cadet JL. Escalated Oxycodone Self-Administration Causes Differential Striatal mRNA Expression of FGFs and IEGs Following Abstinence-Associated Incubation of Oxycodone Craving. Neuroscience 2019;415:173-183. [PMID: 31351142 DOI: 10.1016/j.neuroscience.2019.07.030] [Citation(s) in RCA: 27] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2019] [Revised: 07/08/2019] [Accepted: 07/16/2019] [Indexed: 12/11/2022]
37
Jiang Y, Murnane KS, Bhattaccharjee SA, Blough BE, Banga AK. Skin Delivery and Irritation Potential of Phenmetrazine as a Candidate Transdermal Formulation for Repurposed Indications. AAPS JOURNAL 2019;21:70. [PMID: 31152318 DOI: 10.1208/s12248-019-0335-9] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/28/2018] [Accepted: 04/16/2019] [Indexed: 01/18/2023]
38
Sarabu S, Bandari S, Kallakunta VR, Tiwari R, Patil H, Repka MA. An update on the contribution of hot-melt extrusion technology to novel drug delivery in the twenty-first century: part II. Expert Opin Drug Deliv 2019;16:567-582. [PMID: 31046479 DOI: 10.1080/17425247.2019.1614912] [Citation(s) in RCA: 39] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
39
Kinzler ER, Pantaleon C, Iverson MS, Aigner S. Syringeability of morphine ARER, a novel, abuse-deterrent, extended-release morphine formulation. THE AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE 2019;45:377-384. [DOI: 10.1080/00952990.2019.1599383] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
40
Externbrink A, Sharan S, Sun D, Jiang W, Keire D, Xu X. An in vitro approach for evaluating the oral abuse deterrence of solid oral extended-release opioids with properties intended to deter abuse via chewing. Int J Pharm 2019;561:305-313. [DOI: 10.1016/j.ijpharm.2019.03.017] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2019] [Revised: 03/05/2019] [Accepted: 03/07/2019] [Indexed: 10/27/2022]
41
Moningka H, Lichenstein S, Worhunsky PD, DeVito EE, Scheinost D, Yip SW. Can neuroimaging help combat the opioid epidemic? A systematic review of clinical and pharmacological challenge fMRI studies with recommendations for future research. Neuropsychopharmacology 2019;44:259-273. [PMID: 30283002 PMCID: PMC6300537 DOI: 10.1038/s41386-018-0232-4] [Citation(s) in RCA: 49] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/12/2018] [Revised: 09/11/2018] [Accepted: 09/18/2018] [Indexed: 02/04/2023]
42
Ellis MS, Cicero TJ, Dart RC, Green JL. Understanding multi-pill ingestion of prescription opioids: Prevalence, characteristics, and motivation. Pharmacoepidemiol Drug Saf 2018;28:117-121. [PMID: 30411819 DOI: 10.1002/pds.4687] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2017] [Revised: 07/27/2018] [Accepted: 09/05/2018] [Indexed: 11/07/2022]
43
Cornett EM, Budish R, Latimer D, Hart B, Urman RD, Kaye AD. Management of Challenging Pharmacologic Issues in Chronic Pain and Substance Abuse Disorders. Anesthesiol Clin 2018;36:615-626. [PMID: 30390782 DOI: 10.1016/j.anclin.2018.07.009] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
44
Earp BE, Silver JA, Mora AN, Blazar PE. Implementing a Postoperative Opioid-Prescribing Protocol Significantly Reduces the Total Morphine Milligram Equivalents Prescribed. J Bone Joint Surg Am 2018;100:1698-1703. [PMID: 30278000 DOI: 10.2106/jbjs.17.01307] [Citation(s) in RCA: 66] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
45
Bond M, Schoedel KA, Rabinovich-Guilatt L, Gasior M, Tracewell W, Malamut R, Ma Y, Webster LR. Evaluation of the Relative Intranasal Abuse Potential of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users. PAIN MEDICINE 2018;19:1597-1612. [PMID: 29016880 PMCID: PMC6084602 DOI: 10.1093/pm/pnx133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/05/2022]
46
Eid AI, DePesa C, Nordestgaard AT, Kongkaewpaisan N, Lee JM, Kongwibulwut M, Han K, Mendoza A, Rosenthal M, Saillant N, Lee J, Fagenholz P, King D, Velmahos G, Kaafarani HMA. Variation of Opioid Prescribing Patterns among Patients undergoing Similar Surgery on the Same Acute Care Surgery Service of the Same Institution: Time for Standardization? Surgery 2018;164:926-930. [PMID: 30049481 DOI: 10.1016/j.surg.2018.05.047] [Citation(s) in RCA: 72] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2018] [Revised: 05/11/2018] [Accepted: 05/26/2018] [Indexed: 10/28/2022]
47
Adler JA, Mallick-Searle T. An overview of abuse-deterrent opioids and recommendations for practical patient care. J Multidiscip Healthc 2018;11:323-332. [PMID: 30026658 PMCID: PMC6045950 DOI: 10.2147/jmdh.s166915] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]  Open
48
Brooks A, Kominek C. ADF: Abuse-Deterrent Formulation or Another Disillusioned Formulation? PAIN MEDICINE 2018;19:907-909. [PMID: 29025056 DOI: 10.1093/pm/pnx232] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
49
Intranasal Pharmacokinetics of Morphine ARER, a Novel Abuse-Deterrent Formulation: Results from a Randomized, Double-Blind, Four-Way Crossover Study in Nondependent, Opioid-Experienced Subjects. Pain Res Manag 2018;2018:7276021. [PMID: 29849845 PMCID: PMC5937443 DOI: 10.1155/2018/7276021] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2017] [Revised: 03/01/2018] [Accepted: 03/25/2018] [Indexed: 11/17/2022]
50
Salwan AJ, Hagemeier NE, Harirforoosh S. Abuse-Deterrent Opioid Formulations: A Key Ingredient in the Recipe to Prevent Opioid Disasters? Clin Drug Investig 2018;38:573-577. [DOI: 10.1007/s40261-018-0651-3] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
PrevPage 1 of 2 12Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA